SHUKRA PHARMACEUTICALS
|
The Current P/S Ratio of SHUKRA PHARMACEUTICALS is 22.31.
| Share Price | ₹32.4 | Apr 13,2026 |
| Market Cap | ₹1,420.5 Cr | |
| Sales-TTM | ₹63.7 Cr | TTM-Standalone Results |
| Price/Sales | 22.31x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SHUKRA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,420.5 Cr] as on Apr 13,2026
(/) Sales [ ₹63.7 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 22.31x ]
Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay '22.31 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SHUKRA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SHUKRA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SHUKRA PHARMACEUTICALS
PS Ratio Performance Analysis for SHUKRA PHARMACEUTICALS
- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.11x.
- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 0.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 29.36x.
- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0.31x.
How does SHUKRA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SHUKRA PHARMACEUTICALS | 63.7 | 22.31 | 1,420.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 6.98 | 396,370.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.63 | 161,193.0 |
| CIPLA LTD | 28,351.1 | 3.45 | 97,846.7 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.10 | 141,438.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.97 | 103,097.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.17 | 85,841.5 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.56 | 92,885.5 |
| LUPIN LTD | 26,150.5 | 4.04 | 105,716.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.34 | 77,807.1 |
| ABBOTT INDIA LTD | 6,824.1 | 8.01 | 54,665.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SHUKRA PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.34x |
| Max industry PS | 22.31x |
| Median industry PS | 6.17x |
| Average industry PS | 7.87x |
You may also like the below Video Courses